Uric Acid and Routine Laboratory Variables, but Not Mitochondrial DNA Copy Number, Independently Predict Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Prospective Cohort Study

Objective: Intravenous immunoglobulin (IVIG) resistance affects 10–20% of children with Kawasaki disease (KD) and identifies patients at high risk of treatment failure. We previously showed that peripheral blood mitochondrial DNA copy number (mtDNA-CN) predicts persistent coronary artery dilation. Here we comprehensively evaluated the predictive value of mtDNA-CN for IVIG resistance using a prespecified, multistep analytical strategy and constructed a validated clinical prediction model from routine laboratory variables. Methods: In this prospective single-center cohort (West China Second University Hospital, March 2020 to March 2022), 134 children with KD were analyzed at the patient level. mtDNA-CN was quantified by qPCR before IVIG. Because the leukocyte differential and its percentages vary physiologically with age in young children, absolute leukocyte counts and derived indices, rather than differential percentages, were used in the primary analysis, and age-adjusted and age-restricted (<5 years) sensitivity analyses were performed. Analyses included univariable and multivariable logistic regression with cluster-representative backward AIC selection (mtDNA-CN forced in, robust standard errors), multiple imputation (m = 20), LASSO-penalized regression, restricted cubic splines, interaction and subgroup analyses, bootstrap internal validation (2000 resamples), incremental value analysis (DeLong test, ΔAUC, IDI, NRI), comparison with a Kobayashi-like clinical score, and decision curve analysis. Results: Forty-four patients (32.8%) were IVIG resistant. In univariable analysis, lower mtDNA-CN was borderline associated with resistance (OR 0.36, 95% CI 0.13–1.00, p = 0.050). In the final multivariable model (complete-case n = 133, 43 events), lower uric acid (OR 0.9865 per μmol/L, 95% CI 0.9785–0.9946, p = 0.001), higher indirect bilirubin (OR 1.434, 95% CI 1.099–1.871, p = 0.008), a higher neutrophil-to-lymphocyte ratio (NLR; OR 1.139 per unit, 95% CI 1.021–1.271, p = 0.020) and lower albumin (OR 0.884 per g/L, 95% CI 0.782–0.998, p = 0.047) were independent predictors, whereas mtDNA-CN was not (OR 0.559, 95% CI 0.143–2.189, p = 0.404); rash was retained in the model with a consistent but borderline association (OR 3.053, 95% CI 0.943–9.881, p = 0.063). Multiple imputation and LASSO confirmed these findings. mtDNA-CN correlated with uric acid (Spearman ρ = 0.222, p = 0.013), showed no nonlinear (p = 0.348) or interaction effects, and its subgroup associations were not statistically heterogeneous. The clinical model achieved an AUC of 0.836 (bootstrap-corrected 0.812) and outperformed a Kobayashi-like score (AUC 0.603 in the same analysis set, 0.606 among all 134 patients; DeLong p < 0.001); adding mtDNA-CN did not improve discrimination (ΔAUC +0.009, p = 0.294). At the Youden-optimal risk threshold of 0.37, the nomogram yielded a sensitivity of 0.77 and specificity of 0.83; thresholds targeting 90% sensitivity (0.16; achieved 0.91) and 90% specificity (0.45; achieved 0.89) are provided for rule-out and rule-in strategies. Conclusions: mtDNA-CN is associated with IVIG resistance only in univariable analysis and does not add predictive value beyond routine laboratory variables. Hypo-uricemia emerged as a novel, independent predictor of IVIG resistance, biologically concordant with mtDNA-CN and consistent with oxidant-antioxidant interplay. A five-variable routine-laboratory nomogram predicted IVIG resistance with moderate-to-good, internally validated accuracy and superior performance to a Kobayashi-like score, but requires multicenter external validation before clinical use.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-20
DOI
https://doi.org/10.3390/jcm15229097
Primary Topic
Kawasaki Disease and Coronary Complications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Uric Acid and Routine Laboratory Variables, but Not Mitochondrial DNA Copy Number, Independently Predict Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Prospective Cohort Study

Fan Ma, Peng Yue, Yifei Li, Letao Zhou
1 links
Journal of Clinical Medicine
Kawasaki Disease and Coronary Complications
article

Uric Acid and Routine Laboratory Variables, but Not Mitochondrial DNA Copy Number, Independently Predict Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Prospective Cohort Study

Fan Ma, Peng Yue, Yifei Li, Letao Zhou
article en

Abstract

Objective: Intravenous immunoglobulin (IVIG) resistance affects 10–20% of children with Kawasaki disease (KD) and identifies patients at high risk of treatment failure. We previously showed that peripheral blood mitochondrial DNA copy number (mtDNA-CN) predicts persistent coronary artery dilation. Here we comprehensively evaluated the predictive value of mtDNA-CN for IVIG resistance using a prespecified, multistep analytical strategy and constructed a validated clinical prediction model from routine laboratory variables. Methods: In this prospective single-center cohort (West China Second University Hospital, March 2020 to March 2022), 134 children with KD were analyzed at the patient level. mtDNA-CN was quantified by qPCR before IVIG. Because the leukocyte differential and its percentages vary physiologically with age in young children, absolute leukocyte counts and derived indices, rather than differential percentages, were used in the primary analysis, and age-adjusted and age-restricted (<5 years) sensitivity analyses were performed. Analyses included univariable and multivariable logistic regression with cluster-representative backward AIC selection (mtDNA-CN forced in, robust standard errors), multiple imputation (m = 20), LASSO-penalized regression, restricted cubic splines, interaction and subgroup analyses, bootstrap internal validation (2000 resamples), incremental value analysis (DeLong test, ΔAUC, IDI, NRI), comparison with a Kobayashi-like clinical score, and decision curve analysis. Results: Forty-four patients (32.8%) were IVIG resistant. In univariable analysis, lower mtDNA-CN was borderline associated with resistance (OR 0.36, 95% CI 0.13–1.00, p = 0.050). In the final multivariable model (complete-case n = 133, 43 events), lower uric acid (OR 0.9865 per μmol/L, 95% CI 0.9785–0.9946, p = 0.001), higher indirect bilirubin (OR 1.434, 95% CI 1.099–1.871, p = 0.008), a higher neutrophil-to-lymphocyte ratio (NLR; OR 1.139 per unit, 95% CI 1.021–1.271, p = 0.020) and lower albumin (OR 0.884 per g/L, 95% CI 0.782–0.998, p = 0.047) were independent predictors, whereas mtDNA-CN was not (OR 0.559, 95% CI 0.143–2.189, p = 0.404); rash was retained in the model with a consistent but borderline association (OR 3.053, 95% CI 0.943–9.881, p = 0.063). Multiple imputation and LASSO confirmed these findings. mtDNA-CN correlated with uric acid (Spearman ρ = 0.222, p = 0.013), showed no nonlinear (p = 0.348) or interaction effects, and its subgroup associations were not statistically heterogeneous. The clinical model achieved an AUC of 0.836 (bootstrap-corrected 0.812) and outperformed a Kobayashi-like score (AUC 0.603 in the same analysis set, 0.606 among all 134 patients; DeLong p < 0.001); adding mtDNA-CN did not improve discrimination (ΔAUC +0.009, p = 0.294). At the Youden-optimal risk threshold of 0.37, the nomogram yielded a sensitivity of 0.77 and specificity of 0.83; thresholds targeting 90% sensitivity (0.16; achieved 0.91) and 90% specificity (0.45; achieved 0.89) are provided for rule-out and rule-in strategies. Conclusions: mtDNA-CN is associated with IVIG resistance only in univariable analysis and does not add predictive value beyond routine laboratory variables. Hypo-uricemia emerged as a novel, independent predictor of IVIG resistance, biologically concordant with mtDNA-CN and consistent with oxidant-antioxidant interplay. A five-variable routine-laboratory nomogram predicted IVIG resistance with moderate-to-good, internally validated accuracy and superior performance to a Kobayashi-like score, but requires multicenter external validation before clinical use.

Journal of Clinical MedicineVol. 15(22)
Sichuan University (CN), West China Second University Hospital of Sichuan University (CN)
National Natural Science Foundation of China
Good health and well-being
Kawasaki Disease and Coronary Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon